UAB Hematology Review 2021
2021 Updates on the Use of DOACs: Which GI/GU Patients Are Suitable Candidates? Are DOACs Recommended for Obese Patients? Is Rivaroxaban Beneficial for Arterial Thrombosis?
By
UAB Hematology Review 2021
FEATURING
Jori May
By
UAB Hematology Review 2021
FEATURING
Jori May
Login to view comments.
Click here to Login
